Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CV Sciences, Inc.CVSI · Entity 8316 | 10% owner | January 13, 2021 | February 09, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CV Sciences, Inc.
Report date January 13, 2021 · Filed February 09, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,928,660 |
Reported balance
After 2021-01-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-01-13 · Sale · Disposed 100,000 · Balance 1,928,660 F1: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.60 to $0.62 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 1,828,660 |
Reported balance
After 2021-01-14 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2021-01-14 · Sale · Disposed 100,000 · Balance 1,828,660 F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.619 to $0.64 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 1,812,060 |
Reported balance
After 2021-01-15 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2021-01-15 · Sale · Disposed 16,600 · Balance 1,812,060 F3: As of the date of this filing, the reporting person owns a total of 1,986,722 shares of common stock of the issuer, of which, the reporting person indirectly owns 174,662 shares of common stock of the issuer through Aegean Limited LLC, and directly owns 1,812,060 shares of common stock of the issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.60 to $0.62 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.619 to $0.64 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: As of the date of this filing, the reporting person owns a total of 1,986,722 shares of common stock of the issuer, of which, the reporting person indirectly owns 174,662 shares of common stock of the issuer through Aegean Limited LLC, and directly owns 1,812,060 shares of common stock of the issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 15, 2021 Filed Feb 9, 2021 22:46 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 16,600 | $0.66 | $10,939.40 |
DisclosureSEC source: 0001572795-21-000002 · primary_doc.xml · nonDerivative · entry 3 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,812,060 F3 · balance_after: As of the date of this filing, the reporting person owns a total of 1,986,722 shares of common stock of the issuer, of which, the reporting person indirectly owns 174,662 shares of common stock of the issuer through Aegean Limited LLC, and directly owns 1,812,060 shares of common stock of the issuer. Read SEC document |
| January 14, 2021 Filed Feb 9, 2021 22:46 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 100,000 | $0.63 | $62,950.00 |
DisclosureSEC source: 0001572795-21-000002 · primary_doc.xml · nonDerivative · entry 2 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,828,660 F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.619 to $0.64 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 13, 2021 Filed Feb 9, 2021 22:46 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 100,000 | $0.61 | $61,070.00 |
DisclosureSEC source: 0001572795-21-000002 · primary_doc.xml · nonDerivative · entry 1 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,928,660 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.60 to $0.62 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2021 Filed Jan 19, 2021 21:51 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 75,140 | $0.57 | $42,882.40 |
DisclosureSEC source: 0001572795-21-000001 · primary_doc.xml · nonDerivative · entry 2 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,028,660 F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.562134 to $0.59 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: As of the date of this filing, the reporting person owns a total of 2,203,322 shares of common stock of the issuer, of which, the reporting person indirectly owns 174,662 shares of common stock of the issuer through Aegean Limited LLC, and directly owns 2,028,660 shares of common stock of the issuer. Read SEC document |
| January 06, 2021 Filed Jan 19, 2021 21:51 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 75,000 | $0.56 | $41,625.00 |
DisclosureSEC source: 0001572795-21-000001 · primary_doc.xml · nonDerivative · entry 1 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,103,800 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.55 to $0.56 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 02, 2020 Filed Dec 8, 2020 18:19 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 42,800 | $0.61 | $26,197.88 |
DisclosureSEC source: 0001572795-20-000005 · primary_doc.xml · nonDerivative · entry 3 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,178,800 F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.601 to $0.619 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: As of the date of this filing, the reporting person owns a total of 2,353,462 shares of common stock of the issuer, of which, the reporting person indirectly owns 174,662 shares of common stock of the issuer through Aegean Limited LLC, and directly owns 2,178,800 shares of common stock of the issuer. Read SEC document |
| December 01, 2020 Filed Dec 8, 2020 18:19 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 57,400 | $0.61 | $35,232.12 |
DisclosureSEC source: 0001572795-20-000005 · primary_doc.xml · nonDerivative · entry 2 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,221,600 F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.6116 to $0.624 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 30, 2020 Filed Dec 8, 2020 18:19 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 400,000 | $0.59 | $234,520.00 |
DisclosureSEC source: 0001572795-20-000005 · primary_doc.xml · nonDerivative · entry 1 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,279,000 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.4951 to $0.719 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 30, 2020 Filed Aug 4, 2020 00:14 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 58,535 | $0.58 | $33,956.15 |
DisclosureSEC source: 0001572795-20-000004 · primary_doc.xml · nonDerivative · entry 2 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 174,662 F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.57 to $0.59 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: As of the date of this filing, the reporting person owns a total of 2,853,662 shares of common stock of the issuer, of which, the reporting person indirectly owns 174,662 shares of common stock of the issuer through Aegean Limited LLC, and directly owns 2,679,000 shares of common stock of the issuer. F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| July 29, 2020 Filed Aug 4, 2020 00:14 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 50,000 | $0.58 | $29,170.00 |
DisclosureSEC source: 0001572795-20-000004 · primary_doc.xml · nonDerivative · entry 1 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 233,197 F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.58 to $0.59 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| June 10, 2020 Filed Jun 20, 2020 00:31 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 8,803 | $0.80 | $7,042.40 |
DisclosureSEC source: 0001572795-20-000003 · primary_doc.xml · nonDerivative · entry 2 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 283,197 F2 · balance_after: As of the date of this filing, the reporting person owns a total of 2,962,197 shares of common stock of the issuer, of which, the reporting person indirectly owns 283,197 shares of common stock of the issuer through Aegean Limited LLC, and directly owns 2,679,000 shares of common stock of the issuer. F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| May 22, 2020 Filed Jun 20, 2020 00:31 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 30,000 | $0.80 | $24,000.00 |
DisclosureSEC source: 0001572795-20-000003 · primary_doc.xml · nonDerivative · entry 1 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 292,000 F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| May 05, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 136,285 | $0.47 | $64,162.98 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 23 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,679,000 F9 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.46 to $0.48 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F10 · balance_after: As of the date of this filing, the reporting person owns a total of 3,001,000 shares of common stock of the issuer, of which, the reporting person indirectly owns 322,000 shares of common stock of the issuer through Aegean Limited LLC, and directly owns 2,679,000 shares of common stock of the issuer. Read SEC document |
| May 04, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 109,239 | $0.48 | $52,063.31 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 22 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,815,285 F8 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.47 to $0.49 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 01, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 42,790 | $0.48 | $20,684.69 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 21 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,924,524 F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.47 to $0.50 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 30, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 16,840 | $0.51 | $8,655.76 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 20 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,967,314 Read SEC document |
| April 29, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 84,575 | $0.53 | $44,968.53 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 19 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,984,154 F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.52 to $0.54 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 28, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 5,650 | $0.54 | $3,073.60 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 18 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,068,729 Read SEC document |
| April 27, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 207,226 | $0.52 | $107,944.02 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 17 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,074,379 F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.5 to $0.54 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 23, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 42,774 | $0.51 | $21,998.67 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 16 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,281,605 F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.51 to $0.52 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 22, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 278,421 | $0.50 | $139,683.82 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 15 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,324,379 F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.485 to $0.52 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 21, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 77,200 | $0.52 | $40,483.68 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 14 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,602,800 F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.52 to $0.535 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 26, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 25,000 | $0.70 | $17,500.00 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 13 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 322,000 F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| February 14, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 45,000 | $0.95 | $42,750.00 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 12 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 347,000 F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| February 11, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 8,000 | $0.95 | $7,600.00 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 11 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 392,000 F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| January 20, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 80,000 | $1.20 | $96,000.00 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 10 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 400,000 F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| January 15, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 50,000 | $1.20 | $60,000.00 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 9 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 480,000 F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| January 14, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 50,000 | $1.15 | $57,500.00 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 8 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 530,000 F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| January 14, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 50,000 | $1.05 | $52,500.00 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 7 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 580,000 F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| January 09, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 25,000 | $1.01 | $25,260.00 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 6 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 630,000 F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| January 09, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 12,500 | $1.02 | $12,750.00 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 5 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 655,000 F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| January 09, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 12,500 | $1.02 | $12,750.00 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 4 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 667,500 F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| January 09, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 25,221 | $1.00 | $25,221.00 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 3 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 680,000 F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| January 08, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 18,400 | $1.00 | $18,400.00 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 2 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 705,221 F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| January 07, 2020 Filed May 12, 2020 00:59 UTC | CV Sciences, Inc. CVSI · Entity 8316 | SaleCommon Stock | 6,379 | $1.00 | $6,379.00 |
DisclosureSEC source: 0001572795-20-000002 · primary_doc.xml · nonDerivative · entry 1 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Aegean Limited LLC Disclosed balance after: 723,621 F1 · ownership.nature: The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any. Read SEC document |
| January 10, 2019 Filed Jan 15, 2019 01:01 UTC | CV Sciences, Inc. CVSI · Entity 8316 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001683168-19-000097 · ownership.xml · derivative · entry 4 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2027-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested on the date of grant. Read SEC document |
| January 10, 2019 Filed Jan 15, 2019 01:01 UTC | CV Sciences, Inc. CVSI · Entity 8316 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 530,000 | $0.00 Strike: $0.16 | $0.00 |
DisclosureSEC source: 0001683168-19-000097 · ownership.xml · derivative · entry 3 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 530,000 shares Expires 2025-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested on the date of grant. Read SEC document |
| January 10, 2019 Filed Jan 15, 2019 01:01 UTC | CV Sciences, Inc. CVSI · Entity 8316 | Exercise / conversionCommon Stock | 200,000 | $0.38 | $76,000.00 |
DisclosureSEC source: 0001683168-19-000097 · ownership.xml · nonDerivative · entry 2 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 730,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2019 Filed Jan 15, 2019 01:01 UTC | CV Sciences, Inc. CVSI · Entity 8316 | Exercise / conversionCommon Stock | 530,000 | $0.16 | $82,150.00 |
DisclosureSEC source: 0001683168-19-000097 · ownership.xml · nonDerivative · entry 1 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2018 Filed Jun 14, 2018 21:07 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantRestricted Stock Units · Derivative | 2,950,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-18-001694 · mmona_frm4.xml · derivative · entry 2 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,950,000 Underlying: Common Stock · 2,950,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 983,323 of the restricted stock units vest on June 8, 2019 and the remaining restricted stock units vest in twenty-four equal monthly increments thereafter. Vested shares will be delivered to Reporting Person within ten (10) business days of the vesting date. Notwithstanding the foregoing, in the event the Issuer reasonably anticipates that the issuance of the vested shares would constitute a violation of federal securities laws or other applicable laws, delivery of the vested shares shall be delayed until the earliest date at which the Issuer reasonably anticipates issuing the vested shares will not cause such a violation. F3 · derivative.expiration_date: 983,323 of the restricted stock units vest on June 8, 2019 and the remaining restricted stock units vest in twenty-four equal monthly increments thereafter. Vested shares will be delivered to Reporting Person within ten (10) business days of the vesting date. Notwithstanding the foregoing, in the event the Issuer reasonably anticipates that the issuance of the vested shares would constitute a violation of federal securities laws or other applicable laws, delivery of the vested shares shall be delayed until the earliest date at which the Issuer reasonably anticipates issuing the vested shares will not cause such a violation. Read SEC document |
| March 20, 2018 Filed Jun 14, 2018 21:07 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantEmployee Stock Option (right to buy) · Derivative | 1,050,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001683168-18-001694 · mmona_frm4.xml · derivative · entry 1 Mona Michael Joseph Jr · CIK 0001572795 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050,000 Underlying: Common Stock · 1,050,000 shares Expires 2028-03-19 F1 · derivative.exercise_date: The stock option is fully vested on the date of grant. Read SEC document |
| July 14, 2017 Filed Mar 28, 2018 12:02 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantEmployee Stock Option (right to buy) · Derivative | 1,250,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001683168-18-000772 · monajr_f4.xml · derivative · entry 2 Mona Michael Joseph Jr · CIK 0001572795 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Stock · 1,250,000 shares Expires 2027-03-14 F3 · derivative.underlying_shares: On March 15, 2017, the Reporting Person was granted an option to purchase 5,000,000 shares of the Issuer's Common Stock. The option is performance-based, and vests and becomes exercisable as follows: (i) when the Company has final meeting minutes from a pre-IND meeting as authorized by the FDA for a drug development program utilizing CBD as the active pharmaceutical ingredient (25% vesting of the shares subject to the option); (ii) when the Company is granted an IND (25% vesting of the shares subject to the option); and (iii) when the Company commences its first human dosing under the IND (50% vesting of the shares subject to the option). On July 14, 2017, the first performance criterion was met resulting in vesting of the option as to 1,250,000 shares. Read SEC document |
| July 14, 2017 Filed Mar 28, 2018 12:02 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantEmployee Stock Option (right to buy) · Derivative | 1,500,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001683168-18-000772 · monajr_f4.xml · derivative · entry 1 Mona Michael Joseph Jr · CIK 0001572795 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500,000 Underlying: Common Stock · 1,500,000 shares Expires 2026-07-05 F1 · derivative.underlying_shares: On July 6, 2016, the Reporting Person was granted an option to purchase 6,000,000 shares of the Issuer's Common Stock. The option is performance-based, and vests and becomes exercisable as follows: (i) the first time the Issuer completes development of a U.S. Food & Drug Administration ("FDA") current good manufacturing practice grade batch of successfully synthetically formulated Cannabidiol ("CBD") for use in drug development activities (25% vesting of the shares subject to the option); (ii) when the Company has final meeting minutes from a pre-investigational new drug application ("IND") meeting as authorized by the FDA for a drug development program utilizing CBD as the active pharmaceutical ingredient (25% vesting of the shares subject to the option); (iii) when the Company is granted an IND (25% vesting of the shares subject to the option); and (iv) when the Company commences its first human dosing under the IND (25% vesting of the shares subject to the option). F2 · derivative.underlying_shares: On July 14, 2017, the second performance criterion was met resulting in vesting of the option as to 1,500,000 shares. Read SEC document |
| March 15, 2017 Filed Mar 30, 2017 20:52 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantEmployee Stock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001144204-17-017737 · v462984_4.xml · derivative · entry 1 Mona Michael Joseph Jr · CIK 0001572795 · Director · CEO and President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2027-03-14 F1 · derivative.exercise_date: The option is fully vested on the date of grant. Read SEC document |
| October 05, 2016 Filed Oct 17, 2016 22:50 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantEmployee Stock Option (right to buy) · Derivative | 1,500,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001683168-16-000333 · monamj_frm4.xml · derivative · entry 1 Mona Michael Joseph Jr · CIK 0001572795 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500,000 Underlying: Common Stock · 1,500,000 shares Expires 2026-07-05 F1 · balance_after: See remarks below. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.